Nilotinib bests imatinib in chronic myeloid leukemiaQuestions about tolerability and cost of treatment need answering before clinical practice should change Statins benefit leukemia patientsClinical trials needed to pinpoint ideal candidates Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen FPs should take lead in reducing breast cancer risk Online tool helps family doctors screen women to detect higher-risk patients Rethinking breast cancer Chemo- trastuzumab combo ups survival Wait times for diagnosis exceed accepted targets Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Groups collaborate on chronic disease prevention $15.5M invested in chronic disease prevention by Canadian Partnership Against Cancer Nova Scotia, Newfoundland form breast cancer screening partnership First Previous 69 70 71 72 73 Next Last
